Immunotherapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2022-08-11 ms8000001133714778

请教各位前辈，In peer review大概多久？

64 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2022-09-01 烂泥

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：免疫;肿瘤
经验分享：还行

63 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2022-04-06 ms7000000468797701

2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2020-06-29 458457liu

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：免疫治疗
经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。
也可能是疫情原因吧。

192 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

引言和讨论如何写的不重复？

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

怎么撰写引言？区别于讨论？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2020-11-27 yusheng6016

审稿速度:3.0 | 投稿命中率:75.0
经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿#肿瘤#版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投

495 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2020-04-22 杨药师

请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表:
这个杂志看起来还行，医学3区。

wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。

193 0

[GetPortalCommentsPageByObjectIdResponse(id=1238085, encodeId=0e46123808530, content=请教各位前辈，In peer review大概多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cca95586907, createdName=ms8000001133714778, createdTime=Thu Aug 11 16:34:05 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242575, encodeId=157012425e508, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aff8117066, createdName=烂泥, createdTime=Thu Sep 01 22:57:35 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208988, encodeId=3762120898883, content=2021.07.21 投稿，投稿三个月后催稿，编辑反馈很快，20221.11.22返回小修，小修三个月后开始催稿，每周1封催稿信，共发送4封，所有催稿信编辑均未回复。最后一封催稿信发送1周后，显示接收，接收日期2022.03.29。整个投稿过程共历时8个月。着急需要文章的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee625502595, createdName=ms7000000468797701, createdTime=Wed Apr 06 14:52:50 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800311, encodeId=e34d80031183, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：伦敦人，效率低，不建议投。内审1-1.5周，外审1-1.5个月，major revision后2.5个月回复，其中催了2次。 也可能是疫情原因吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iafVf8OHG4eHwsKhNUs5hAsrdJSFS66q1dIs9el2AqDE0NOR92fIOgae6xp1ia1GlzCbXSpZAD9zUselTXWyvhOA/132, createdBy=1a072404335, createdName=458457liu, createdTime=Mon Jun 29 19:05:10 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103424, encodeId=507b110342464, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103423, encodeId=4835110342376, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902658, encodeId=3c91902658a4, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：今年6.19投了一篇，中间催稿一次，一审外审2月大修，二审外审接近2月小修，三审1周小修后接受，今天已online。总体来说，编辑态度好，很负责很细心，很多小毛病都能挑出来，投稿<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>版面偏复杂，文件多。外审周期稍长，小修后效率就很快，有问题编辑也会及时发邮件沟通。版面费偏贵，3k刀。没经费的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=yusheng6016, createdTime=Fri Nov 27 01:30:57 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589486, encodeId=f623589486ac, content=请问多久接收的？wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, beContent=wenxuema_19851601 2018-01-25 00:16:00 发表: 这个杂志看起来还行，医学3区。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/QrAfzjy5NbB6uHQuic53jMiazG25xatSfmLq4T2qc2T5WJuRhIicFcMDMTnLk5Awg75tic4NyBtawybmpCCiajrPVHg/132, createdBy=508c5311913, createdName=杨药师, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551959, encodeId=3c485519599f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这个杂志看起来还行，医学3区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91232134311, createdName=wenxuema_19851601, createdTime=Thu Jan 25 00:16:00 CST 2018, time=2018-01-25, status=1, ipAttribution=)]

2018-01-25 wenxuema_19851601

审稿速度:1.0 | 投稿命中率:50.0
经验分享：这个杂志看起来还行，医学3区。

305 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务